AI-ECG Platform vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Carewell Health
VS
by Bunkerhill Health

AI Verdict

Tool A, the AI-ECG Platform, is designed for the rapid, AI-powered analysis and diagnosis of 12-lead resting ECGs, assisting physicians with immediate cardiac event interpretation. In contrast, Tool B, the iCAC Device, utilizes AI to detect and quantify coronary artery calcium from routine chest CT scans, focusing on early cardiovascular disease risk assessment. While both are FDA-cleared cardiology AI tools, their distinct input data and specific diagnostic applications make them complementary rather than direct competitors.

Choose AI-ECG Platform if…

Choose the AI-ECG Platform if your primary need is rapid, AI-powered automatic analysis and diagnosis of 12-lead resting ECGs. This tool is ideal for clinical settings requiring high-accuracy interpretation of arrhythmias, myocardial ischemia, and infarction to assist physicians in immediate cardiac assessment and report generation.

View AI-ECG Platform →

Choose iCAC Device if…

Choose the iCAC Device if you aim to opportunistically detect and quantify coronary artery calcium from routine, non-contrast chest CT scans. This solution is best suited for radiologists and cardiologists looking to leverage existing imaging data for early cardiovascular disease detection and long-term risk stratification, providing valuable adjunctive information without additional dedicated scans.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-ECG Platform iCAC Device
Pricing Unknown Contact for pricing
Deployment On-premise (AI-ECG Workstation), web-based (Management Portal), and client-based (AI-ECG Diagnostic Client). Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AI-ECG Platform

Tool A (AI-ECG Platform) offers a dedicated web-based Management Portal and a Windows-based Diagnostic Client with rich features for professional ECG review, waveform measurement, and report generation. Its rapid diagnosis in approximately 3 seconds also contributes to a smoother user experience.

Clinical Value

Tie

Both tools are FDA-cleared and provide significant clinical value in cardiovascular care. Tool A offers high-accuracy diagnosis of various cardiovascular diseases from ECGs, while Tool B provides opportunistic early detection and risk stratification of coronary artery calcium from existing CT scans, addressing different but equally important clinical needs.

Pricing & Value

Tie

Neither tool provides transparent pricing information, requiring direct contact with the vendor. Without specific pricing details or further information on their economic value propositions, it is not possible to determine a winner in this dimension.

Enterprise Readiness

iCAC Device

Tool B (iCAC Device) explicitly highlights its deployment as Software as a Medical Device (SaMD) with integration into PACS, DICOM routers, and EHRs via its cloud-based Carebricks platform. This indicates a strong focus on seamless integration within existing enterprise radiology and cardiology workflows.

Innovation

iCAC Device

Tool B (iCAC Device) demonstrates greater innovation by leveraging deep-learning algorithms to opportunistically detect and quantify coronary artery calcium from routine, non-contrast, non-gated chest CT scans, which are often performed for other reasons. This approach maximizes the value of existing data for early disease detection.

Support & Docs

Tie

Neither the provided structured facts nor a web search yielded specific information regarding dedicated support portals, comprehensive documentation, or service level agreements for either tool. Therefore, it is not possible to distinguish between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-ECG Platform iCAC Device
Product Name AI-ECG Platform iCAC Device
Company Shenzhen Carewell Electronics Co., Ltd. Bunkerhill Health
Primary Function/Analysis Focus AI automatic analysis and diagnosis system for 12-lead resting ECGs AI algorithm to detect and quantify coronary artery calcium from chest CT scans
Input Data Type 12-lead resting ECGs (Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, MFER ECG) Routine, non-contrast, non-gated chest CT scans
Key Output/Diagnosis AI-powered automatic ECG analysis and diagnosis, diagnoses arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction Estimates presence and quantity of coronary artery calcium (CAC), provides exact and four-category quantitative estimates of CAC burden in Agatston units
Specialties Supported Cardiology, Emergency Medicine, Internal Medicine Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring AI-ECG Platform and iCAC Device.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The AI-ECG Platform by Shenzhen Carewell Electronics is designed to analyze 12-lead resting ECGs. In contrast, Bunkerhill Health's iCAC Device analyzes routine, non-contrast, non-gated chest CT scans.
The AI-ECG Platform assists physicians in diagnosing arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction with over 95% accuracy for major cardiovascular diseases. The iCAC Device detects and quantifies coronary artery calcium (CAC) from CT scans, providing visual representations and quantitative estimates in Agatston units.
The AI-ECG Platform offers deployment options including a workstation, web-based portal, or a Windows-based diagnostic client, and is hardware independent. The iCAC Device is a Software as a Medical Device (SaMD) that integrates with PACS or a DICOM router and can integrate with EHRs via the Carebricks platform.
The AI-ECG Platform is designed for use in Cardiology, Emergency Medicine, and Internal Medicine. The iCAC Device is primarily intended to support Cardiology and Radiology specialties.
The AI-ECG Platform provides rapid diagnosis in approximately 3 seconds. The iCAC Device analyzes existing CT scans to provide its estimates, though a specific processing time is not detailed.
The AI-ECG Platform supports various ECG data formats, including Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, and MFER ECG, ensuring compatibility with most ECG machines.
AI Tool Finder
AI-powered search. Results may not be comprehensive.